Search
Menu
Rocky Mountain Instruments - Laser Optics LB

Light Sciences Oncology Inc.

Facebook X LinkedIn Email
Light Sciences Oncology Inc. of Seattle has made an agreement with the FDA on a special protocol assessment for a Phase III clinical trial. This will allow the company to compare its light infusion therapy product with another treatment for metastatic colorectal cancer in the liver. The device provides photodynamic therapy, by using LEDs to activate talaporfin sodium. Through production of singlet oxygenmolecules, the light-activated drug induces apoptosis in cells within a defined zone around the LED array.
DataRay Inc. - ISO 11146-Compliant

Published: April 2007
Biophotonicsenergylight infusionLight Sciences Oncology Inc.Light SourcesNews & FeaturesLEDs

We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.